Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells.

Cancer letters - 28 Jul 2013

Jiang Donghai, Sui Meihua, Zhong Wangyan, Huang Yuan, Fan Weimin

Abstract excerpt

Both dose-dense and dose-escalation chemotherapy are administered in clinic. By approximately imitating the schedules of dose-dense and dose-escalation administration with paclitaxel, two novel multidrug resistant (MDR) cell lines Bads-200 and Bats-72 were successfully developed from drug-sensitive breast cancer cell line BCap37, respectively. Different from Bads-200, Bats-72 exhibited stable MDR and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Phytogenic
Share to ATP-Binding Cassette Transporters

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Drug Resistance, Multiple

Share to Mice, Nude

Share to Neoplasm Metastasis

Share to Paclitaxel

Share to Prohibitins

Source

Open in PubMed Open full text

Identifiers

PMID: 23499896
DOI: 10.1016/j.canlet.2013.02.059
PMCID: PMC3669644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells.PMID 23499896Read ↗

Establishment and characterization of a multi-drug resistant cell line for canine mammary tumorsSemantic proximity Read ↗

Key genes and molecular mechanisms related to Paclitaxel ResistanceSemantic proximity Read ↗

Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cellsSemantic proximity Read ↗

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancerSemantic proximity Read ↗

Alteration of the Mitochondrial Apoptotic Pathway Is Key to Acquired Paclitaxel Resistance and Can Be Reversed by ABT-737Semantic proximity Read ↗

Mechanisms of Resistance to CabazitaxelSemantic proximity Read ↗

Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxelSemantic proximity Read ↗

Induction of a multifactorial resistance phenotype by high paclitaxel selective pressure in a human ovarian carcinoma cell line.Semantic proximity Read ↗

Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation TaxanesSemantic proximity Read ↗

Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance.Semantic proximity Read ↗

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.Semantic proximity Read ↗

Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.